Read + Share
Amedeo Smart
Independent Medical Education
Desvaux E, Hamon A, Hubert S, Boudjeniba C, et al. Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19. PLoS One 2021;16:e0254374.PMID: 34293006
Email
LinkedIn
Facebook
Twitter
Privacy Policy